{
    "id": 29557,
    "title": "Bekendtgørelse om fortegnelse over erhvervssygdomme",
    "documentTypeId": "60",
    "isSagsforlobPeriodValid": true,
    "shortName": "BEK nr 918 af 18/11/2002",
    "documentHtml": "<div class=\"bjelke\">Oversigt (indholdsfortegnelse)</div><DIV CLASS=PARA ID=\"OVERSIGT\"> \r\n\r\n\r\n\r\n<UL>  \r\n\r\n</UL>  \r\n\r\n</UL>  \r\n\r\n</UL>  \r\n\r\n<table border=\"0\"><tr><td valign=\"top\" width=\"130\"><A HREF=\"#B1\">Bilag  \r\n\r\n 1</A></td><td></td></table>  \r\n\r\n<table border=\"0\"><tr><td valign=\"top\" width=\"130\"><A HREF=\"#B2\">Bilag  \r\n\r\n 2</A></td><td></td></table>  \r\n\r\n<table border=\"0\"><tr><td valign=\"top\" width=\"130\"><A HREF=\"#B3\">Bilag  \r\n\r\n 3</A></td><td></td></table>  \r\n\r\n</DIV><div class=\"bjelke\">Den fulde tekst</div><DIV CLASS=PARA ID=\"INDHOLD\"> \r\n\r\n\r\n<FONT SIZE=5><P ALIGN=\"CENTER\">Bekendtg&oslash;relse om fortegnelse over  \r\n\r\n erhvervssygdomme</P>  \r\n\r\n</FONT>  \r\n\r\n<P>&nbsp;</P>  \r\n\r\n<P>I medf&oslash;r af §&nbsp;10, stk.&nbsp;1, nr. 1, 3. pkt., i lov om  \r\n\r\n sikring mod f&oslash;lger af arbejdsskade, jf. lovbekendtg&oslash;relse nr.  \r\n\r\n 943 af 16. oktober 2000, og §&nbsp;11, stk.&nbsp;1, nr. 1, 3. pkt., i  \r\n\r\n anordning nr. 273 af 24. april 2001 om ikrafttr&aelig;den af lov om sikring  \r\n\r\n mod f&oslash;lger af arbejdsskade i Gr&oslash;nland, fasts&aelig;ttes:</P>  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P1\">  \r\n\r\n<P CLASS=PARAB><B>§&nbsp;1.</B> For at en sygdom kan anerkendes som  \r\n\r\n erhvervssygdom, jf. lovens §&nbsp;10, stk.&nbsp;1, nr. 1, skal  \r\n\r\n f&oslash;lgende generelle betingelser v&aelig;re opfyldt:</P><DIR>  \r\n\r\n<P>1)&#9;Den skadelige p&aring;virkning skal styrkem&aelig;ssigt og  \r\n\r\n tidsm&aelig;ssigt svare til de p&aring;virkninger, for hvilke der er  \r\n\r\n godtgjort en &aring;rsagsm&aelig;ssig sammenh&aelig;ng mellem  \r\n\r\n p&aring;virkning og sygdom.</P>  \r\n\r\n<P>2)&#9;Der skal v&aelig;re tale om et sygdomsbillede, der svarer til det  \r\n\r\n sygdomsbillede, for hvilket der er godtgjort en &aring;rsagsm&aelig;ssig  \r\n\r\n sammenh&aelig;ng mellem p&aring;virkning og sygdom.</P>  \r\n\r\n<P>3)&#9;Der m&aring; ikke v&aelig;re oplyst forhold, der g&oslash;r det  \r\n\r\n overvejende sandsynligt, at sygdommen skyldes andre forhold end de  \r\n\r\n arbejdsm&aelig;ssige, jf. lov om sikring mod f&oslash;lger af arbejdsskade,  \r\n\r\n §&nbsp;11, stk.&nbsp;1.</P></DIR>  \r\n\r\n<I><P>&nbsp;&nbsp;&nbsp;&nbsp;Stk.&nbsp;2.</I> Hvis der er faktorer, der ikke er arbejdsbetingede,  \r\n\r\n men som antages at medvirke til sygdommen, anerkendes sygdommen som  \r\n\r\n erhvervssygdom med forbehold for s&aring; vidt ang&aring;r disse faktorer,  \r\n\r\n jf. lovens §&nbsp;12, stk.&nbsp;2. Ved erstatningsudm&aring;lingen ydes alene  \r\n\r\n erstatning for den del af sygdommen, der skyldes den erhvervsm&aelig;ssige  \r\n\r\n p&aring;virkning, jf. lovens §&nbsp;26.</P>  \r\n\r\n<I><P>&nbsp;&nbsp;&nbsp;&nbsp;Stk.&nbsp;3.</I> I en r&aelig;kke tilf&aelig;lde g&aelig;lder der  \r\n\r\n endvidere nogle s&aelig;rlige betingelser, som ligeledes skal v&aelig;re  \r\n\r\n opfyldt. Disse betingelser fremg&aring;r af fortegnelsens enkelte  \r\n\r\n punkter.</P>  \r\n\r\n</DIV><!-- End of \"§ 1\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P2\">  \r\n\r\n<P CLASS=PARAB><B>§&nbsp;2.</B> Sygdomme n&aelig;vnt i fortegnelsen i  \r\n\r\n bilag&nbsp;1, jf. bilag&nbsp;2, berettiger til anerkendelse som  \r\n\r\n erhvervssygdomme, n&aring;r s&aring;vel de generelle betingelser i §&nbsp;1  \r\n\r\n som de s&aelig;rlige betingelser n&aelig;vnt i de enkelte punkter i  \r\n\r\n fortegnelsen er opfyldt.</P>  \r\n\r\n</DIV><!-- End of \"§ 2\" -->  \r\n\r\n<DIV CLASS=PARAGRAF ID=\"P3\">  \r\n\r\n<P CLASS=PARAB><B>§&nbsp;3.</B> Bekendtg&oslash;relsen tr&aelig;der i kraft  \r\n\r\n den 1. december 2002 og finder fra denne dato anvendelse ved  \r\n\r\n afg&oslash;relsen af, om en anmeldt lidelse kan anerkendes som  \r\n\r\n erhvervssygdom.</P>  \r\n\r\n<I><P>&nbsp;&nbsp;&nbsp;&nbsp;Stk.&nbsp;2.</I> Samtidig oph&aelig;ves bekendtg&oslash;relse nr. 357  \r\n\r\n af 17. maj 2001 om fortegnelse over erhvervssygdomme.</P>  \r\n\r\n<I><P>&nbsp;&nbsp;&nbsp;&nbsp;Stk.&nbsp;3.</I> Denne bekendtg&oslash;relse finder ligeledes  \r\n\r\n anvendelse ved afg&oslash;relser, der er truffet af Arbejdsskadestyrelsen  \r\n\r\n f&oslash;r bekendtg&oslash;relsens ikrafttr&aelig;den, og som er indbragt for  \r\n\r\n Den Sociale Ankestyrelse. Det g&aelig;lder dog ikke, hvis  \r\n\r\n bekendtg&oslash;relsen sk&aelig;rper de hidtidige betingelser for  \r\n\r\n anerkendelse.</P>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"§ 3\" -->  \r\n\r\n<DIV CLASS=GIVET ID=\"GIVET\">  \r\n\r\n<FONT SIZE=\"3\">  \r\n\r\n<P CLASS=GIVET ALIGN=\"CENTER\"><I>Arbejdsskadestyrelsen, den 18. november  \r\n\r\n 2002</I></P>  \r\n\r\n<P CLASS=SIGN1 ALIGN=\"CENTER\">Anne Lind Madsen</P>  \r\n\r\n<P CLASS=SIGN2 ALIGN=\"RIGHT\">/Karin Holst Jensen</P>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"GIVET\" -->  \r\n\r\n<A NAME=\"\"B1\"\"></A>\r\n\r\n<DIV CLASS=BILAG ID=\"B1\">  \r\n\r\n<HR width=70% align=center>  \r\n\r\n<B><FONT SIZE=4><P ALIGN=\"RIGHT\">Bilag 1</P>  \r\n\r\n</FONT>  \r\n\r\n<P ALIGN=\"CENTER\">Fortegnelse over erhvervssygdomme</P></B>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 WIDTH=529>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe A</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=10>  \r\n\r\n<I><P>Sygdomme, som efter medicinsk og teknisk erfaring kan for&aring;rsages  \r\n\r\n af f&oslash;lgende kemiske stoffer:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\">  \r\n\r\n<I><P>Eksempler p&aring; typiske risikoomr&aring;der evt. med angivelse af et  \r\n\r\n inden for omr&aring;det ofte anvendt kemisk stof:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=10>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Arsen og visse af dets forbindelser:</P>  \r\n\r\n<P>Hudkr&aelig;ft, nervebet&aelig;ndelse (perifer polyneuropati),  \r\n\r\n skrumpelever (cirrhosis hepatis), lungekr&aelig;ft.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kemisk og metallurgisk industri.</P>  \r\n\r\n<P>Medicinalindustri. Fremstilling af syrer og  \r\n\r\n tr&aelig;impr&aelig;gneringsmidler.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Beryllium og visse af dets forbindelser:</P>  \r\n\r\n<P>Berylliumlunge.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Porcel&aelig;ns- og keramikindustri, elektronisk og nuclear (atom)  \r\n\r\n industri.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Kulilte, fosgen, bl&aring;syre, cyansalte, cyanforbindelser og  \r\n\r\n cyanater:</P>  \r\n\r\n<P>Kulilte:</P>  \r\n\r\n<P>Organisk hjerneskade efter sv&aelig;re forgiftningstilf&aelig;lde med  \r\n\r\n bevidstl&oslash;shed.</P>  \r\n\r\n<P>Acrylonitril:</P>  \r\n\r\n<P>Leverbet&aelig;ndelse (hepatitis toxica).</P>  \r\n\r\n<P>Isocyanater:</P>  \r\n\r\n<P>Astma bronchiale og lungelidelse med nedsat lungefunktion af obstruktiv  \r\n\r\n type.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Rum, hvor der forekommer ufuldst&aelig;ndig forbr&aelig;nding. Iltning af  \r\n\r\n klorholdige affedtningsmidler inden for metalindustrien. Galvanisering,  \r\n\r\n st&aring;lh&aelig;rdning samt guld- og s&oslash;lvarbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>4.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Kadmium og visse af dets forbindelser:</P>  \r\n\r\n<P>Nyreskade forenelig med kadmiumforgiftning.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Galvaniserings- og farveindustri.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>5.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Krom og visse af dets forbindelser:</P>  \r\n\r\n<P>Allergisk eksem, astma bronchiale, bet&aelig;ndelser i slimhinder i  \r\n\r\n &oslash;jne og &oslash;vre luftveje, perforation af  \r\n\r\n n&aelig;seskillev&aelig;g, lungekr&aelig;ft efter mange&aring;rig betydelig  \r\n\r\n p&aring;virkning.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Metal- og farveindustri. Cementst&oslash;bning og anvendelse af  \r\n\r\n kromgarvede produkter.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>6.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Kviks&oslash;lv og visse forbindelser heraf:</P>  \r\n\r\n<P>Organisk hjerneskade forenelig med kronisk kviks&oslash;lvforgiftning,  \r\n\r\n nyreskade (nephrotisk syndrom).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Elektrokemisk og elektromekanisk industri. Laboratoriearbejde.  \r\n\r\n Fremstilling af m&aring;leinstrumenter.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>7.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Mangan og visse forbindelser heraf:</P>  \r\n\r\n<P>Rystelammelse (paralysis agitans) efter sv&aelig;r manganeksposition.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af t&oslash;relementer samt lakker og farver.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>8.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Salpetersyre, kv&aelig;lstofilter, ammoniak og dets forbindelser:</P>  \r\n\r\n<P>Varig lungeskade efter sv&aelig;r akut uds&aelig;ttelse.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af kunstg&oslash;dning, spr&aelig;ngstoffer, farver og  \r\n\r\n lakker. Metal&aelig;tsning, gelbbr&aelig;nding. Ved salpetersyreanvendelse og  \r\n\r\n ved forbr&aelig;nding af kv&aelig;lstofholdige produkter  \r\n\r\n (kunstg&oslash;dning), k&oslash;leanl&aelig;g.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>9.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Nikkel og kobolt samt visse forbindelser heraf:</P>  \r\n\r\n<P>Nikkel:</P>  \r\n\r\n<P>Allergisk eksem og lungekr&aelig;ft efter mange&aring;rig betydelig  \r\n\r\n p&aring;virkning.</P>  \r\n\r\n<P>Kobolt:</P>  \r\n\r\n<P>Astma bronchiale, h&aring;rd metallunge.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Specialst&aring;l, m&oslash;nter, smykker.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>10.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Fosfor og visse forbindelser heraf:</P>  \r\n\r\n<P>Polyneuropati, lunge&oslash;dem med varig lungeskade til  \r\n\r\n f&oslash;lge.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af bek&aelig;mpelsesmidler.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>11.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Bly:</P>  \r\n\r\n<P>Tidlig &aring;ndssv&aelig;kkelse (toksisk hjerneskade),  \r\n\r\n nervebet&aelig;ndelse (perifer polyneuropati), nyreskade (kronisk  \r\n\r\n interstitiel nephritis).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Akkumulator-, farve- og plastindustri. Skrotning.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>12.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Svovldioxid, svovlsyre, svovlbrinte:</P>  \r\n\r\n<P>Svovlbrinte:</P>  \r\n\r\n<P>Hjerneskade efter sv&aelig;r akut uds&aelig;ttelse.</P>  \r\n\r\n<P>Svovldioxid og svovlsyre:</P>  \r\n\r\n<P>Lungeskade efter sv&aelig;r akut uds&aelig;ttelse.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af svovlsyre. Papir-, akkumulator-, s&aelig;be- og  \r\n\r\n kunstsilkeindustri.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>13.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Tallium og dets forbindelser:</P>  \r\n\r\n<P>Talliumforgiftning (h&aring;rtab, nervebet&aelig;ndelse og  \r\n\r\n synsforstyrrelser).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af fyrv&aelig;rkeri og rottegift.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>14.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Vanadium og dets forbindelser:</P>  \r\n\r\n<P>Kronisk bronchitis og lungebet&aelig;ndelse.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Fremstilling af specialst&aring;l, farver og lakker.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>15.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Klor, brom og jod samt deres uorganiske forbindelser, fluor og dets  \r\n\r\n forbindelser:</P>  \r\n\r\n<P>Fluorose, varig lungeskade efter sv&aelig;r akut uds&aelig;ttelse.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Disse stoffer (halogenerne) og deres forbindelser forekommer alle i vid  \r\n\r\n udstr&aelig;kning inden for mange industrigrene, f.eks. som blegemidler.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>16.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Kulbrinter og deres derivater:</P>  \r\n\r\n<P>Organiske opl&oslash;sningsmidler:</P>  \r\n\r\n<P>Tidlig &aring;ndssv&aelig;kkelse (toksisk hjerneskade), nyreskade  \r\n\r\n (glomerulonephritis).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kemiske produkter med indhold af organiske opl&oslash;sningsmidler  \r\n\r\n (farver, lakker, rensemidler, r&aring;stoffer fra den kemiske industri og  \r\n\r\n plastindustrien m.m.).</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Klorede opl&oslash;sningsmidler: Leverbet&aelig;ndelse (hepatitis  \r\n\r\n toxica).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Benzen: Blodmangel (aplastisk an&aelig;mi), Blodkr&aelig;ft (myeloid  \r\n\r\n leuk&aelig;mi).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Hexan, metylbutylketon: Nervebet&aelig;ndelse (perifer  \r\n\r\n polyneuropati).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>17.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<P>Organiske kv&aelig;lstof (nitrogen) forbindelser:</P>  \r\n\r\n<P>2-naphtylamin: Bl&aelig;rekr&aelig;ft.</P>  \r\n\r\n<P>Benzidin: Bl&aelig;rekr&aelig;ft.</P>  \r\n\r\n<P>Dimetylformamid: Leverbet&aelig;ndelse (hepatitis toxica).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kemiske produkter med indhold af aminer, nitroaminer m.m. Eksempelvis  \r\n\r\n inden for levnedsmiddel-, farvestof- og spr&aelig;ngstofindustrien.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe B</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Hudsygdomme for&aring;rsaget af stoffer og p&aring;virkninger, der ikke  \r\n\r\n er n&aelig;vnt andetsteds:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Bem&aelig;rkninger:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Hudkr&aelig;ft og pr&aelig;cancer&oslash;se hudlidelser, der skyldes  \r\n\r\n p&aring;virkning af sod, tj&aelig;re, tj&aelig;reholdig asfalt, beg,  \r\n\r\n antracen, mineralske olier, r&aring;parafin og disse stoffers forbindelser,  \r\n\r\n produkter og affald.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Hudlidelser (allergisk eksem) for&aring;rsaget p&aring; arbejdspladsen af  \r\n\r\n stoffer, der ikke er n&aelig;vnt andetsteds, n&aring;r overf&oslash;lsomheden  \r\n\r\n over for stoffet er sikkert p&aring;vist.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Eksempelvis: overf&oslash;lsomhed over for konserveringsmidler,  \r\n\r\n gummitils&aelig;tningsstoffer, latex, f&oslash;devarer m.m.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Andre hudlidelser (f.eks. toksiske eksemer), for&aring;rsaget af stoffer  \r\n\r\n eller p&aring;virkninger, der ikke er n&aelig;vnt andetsteds, n&aring;r der  \r\n\r\n er sikker sammenh&aelig;ng mellem lidelsens fremkomst og best&aring;en og et  \r\n\r\n eller flere irritationsstoffers eller fysiske faktorers tilstedev&aelig;relse  \r\n\r\n i arbejdsmilj&oslash;et.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe C</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Sygdomme fremkaldt ved ind&aring;nding af stoffer, der ikke er  \r\n\r\n n&aelig;vnt andetsteds:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Risikoomr&aring;der:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Silicose.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Sandbl&aelig;sning, jernst&oslash;bning, stenhugning o.l.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Lidelser fremkaldt af asbest:</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Arbejde med isoleringsmaterialer af asbest, asbestcement (eternit),  \r\n\r\n bremsebel&aelig;gninger o.l.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Lungeasbestose.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Udbredt bindev&aelig;vsdannelse i lungehinden med p&aring;virket  \r\n\r\n lungefunktion.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Kr&aelig;ft i lunge- og bughinde (malignt mesotheliom).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>d)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Kr&aelig;ft i lunger (bronchogent carcinom) og luftveje  \r\n\r\n (larynx-cancer).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Lungefibrose for&aring;rsaget af andre silicium-forbindelser.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Arbejde med kaolin, talkum o.l.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>4.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Bronchopulmonale lidelser for&aring;rsaget af st&oslash;v eller dampe fra  \r\n\r\n aluminium eller dets forbindelser samt af st&oslash;v fra h&aring;rde  \r\n\r\n metaller.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Lungelidelser for&aring;rsaget af st&oslash;v og/eller dampe fra de  \r\n\r\n n&aelig;vnte stoffer.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>5.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Astma (allergisk og ikke-allergisk) og rhinitis/conjunktivitis allergica,  \r\n\r\n for&aring;rsaget p&aring; arbejdspladsen, ved ind&aring;nding af st&oslash;v  \r\n\r\n eller dampe fra</P><DIR>  \r\n\r\n<P>a)&#9;planter eller planteprodukter,</P>  \r\n\r\n<P>b)&#9;dyr eller dyriske produkter,</P>  \r\n\r\n<P>c)&#9;enzymer, farvestoffer, persulfatsalte, kunstharpiks eller  \r\n\r\n medikamenter og forstadier til disse,</P>  \r\n\r\n<P>d)&#9;isocyanater og visse anhydrider i epoxyresiner.</DIR>  \r\n\r\n</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Det er en foruds&aelig;tning for anerkendelse, at det  \r\n\r\n sandsynligg&oslash;res, at den arbejdsm&aelig;ssige p&aring;virkning er  \r\n\r\n &aring;rsag til lidelsen. Udl&oslash;sning af symptomer hos en astmatiker  \r\n\r\n efter uds&aelig;ttelse for uspecifikke luftvejsirritanter er ikke omfattet af  \r\n\r\n punktet, medmindre lidelsen varigt forv&aelig;rres.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>6.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Lungelidelse for&aring;rsaget af visse organiske materialer (svampesporer,  \r\n\r\n dyrisk protein o.l.):</P>  \r\n\r\n<P>Allergisk alveolitis, luftfugtersyge, byssinosis.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<I><P>Sygdommens art:</P>  \r\n\r\n</I>  \r\n\r\n<P>»Farmer&#146;s lung«, »mushroom worker&#146;s lung« o.l. og »bird  \r\n\r\n breeder&#146;s lung«.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\">  \r\n\r\n<P>7.</TD>  \r\n\r\n<TD WIDTH=\"45%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Kronisk bronchitis for&aring;rsaget af mange &aring;rs massiv  \r\n\r\n uds&aelig;ttelse for uspecifikt st&oslash;v, herunder st&oslash;v fra  \r\n\r\n isoleringsmaterialer, st&oslash;v fra korn- og foderstoffer, st&oslash;v fra  \r\n\r\n tr&aelig;forarbejdning og r&oslash;g fra svejsning og flammeh&oslash;vling.  \r\n\r\n Hos rygere kan kronisk bronchitis normalt kun anerkendes, hvis  \r\n\r\n tobaksforbruget har v&aelig;ret beskedent.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe D</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Infekti&oslash;se og parasit&aelig;re sygdomme:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Sygdommens art:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Infekti&oslash;se og parasit&aelig;re sygdomme overf&oslash;rt til  \r\n\r\n mennesker fra dyr eller dyrisk materiale. Samme sygdomme for&aring;rsaget af  \r\n\r\n arbejde i renovationsanl&aelig;g, ledningsnet hertil o. l.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Eksempelvis: stivkrampe, ornitose, kalvekastningsfeber, miltbrand, Weil's  \r\n\r\n syge, tuberkul&oslash;s smitte fra dyr.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Infektionssygdomme hos personer, der som led i deres arbejde har haft  \r\n\r\n kontakt med blod, v&aelig;v, v&aelig;vsv&aelig;sker eller andet biologisk  \r\n\r\n materiale fra patienter/personer med samme type infektion.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Eksempelvis: hepatitis, stafylokokker, tuberkulose, AIDS.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Tropesygdomme som f.eks. malaria, am&oslash;biasis, trypanosomiasis,  \r\n\r\n denguefeber, pappatacifeber, maltafeber, tilbagefaldsfeber, gul feber, pest,  \r\n\r\n leishmaniose, framboesi, lepra, plettyfus og andre febersygdomme fremkaldt af  \r\n\r\n richettsia.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe E</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Sygdomme for&aring;rsaget af fysiske p&aring;virkninger:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Bem&aelig;rkninger/sygdommens art:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Sygdomme for&aring;rsaget af ioniserende str&aring;ling.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Visse former for akut leukemi samt kronisk myeloid leukemi</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Gr&aring; st&aelig;r for&aring;rsaget af str&aring;leenergi.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>D&oslash;vhed eller generende tungh&oslash;righed for&aring;rsaget af  \r\n\r\n st&oslash;j.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>4.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Sygdomme for&aring;rsaget af arbejde i komprimeret luft.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>5.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Knogle- og ledsygdomme samt lidelser i kar og nerver for&aring;rsaget af  \r\n\r\n vedvarende vibrationer.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Eksempelvis: &quot;hvide fingre&quot;, neuropati og  \r\n\r\n karpaltunnelsyndrom.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>6.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>F&oslash;lgende lidelser, n&aring;r der <I>ikke</I> har v&aelig;ret tale  \r\n\r\n om varieret arbejde med kvalitativt forskellige arbejdsfunktioner:</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Tendovaginitis (seneskedehindebet&aelig;ndelse), tendinitis og  \r\n\r\n peritendinitis (bet&aelig;ndelse i sener og i v&aelig;vet umiddelbart omkring  \r\n\r\n senerne) p&aring; underarme og h&aelig;nder for&aring;rsaget af uvant og  \r\n\r\n kraftbetonet arbejde, n&aring;r lidelsen opst&aring;r inden for 6  \r\n\r\n m&aring;neder efter det uvante arbejdes p&aring;begyndelse.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Punktet omfatter ikke stenoserende tendovaginitis (springfinger).</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Epicondylitis lateralis (tennisalbue)</P>  \r\n\r\n<I><P>enten</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">  \r\n\r\n<P>i)</TD>  \r\n\r\n<TD WIDTH=\"38%\" VALIGN=\"TOP\">  \r\n\r\n<P>For&aring;rsaget af uvant og kraftbetonet arbejde, n&aring;r lidelsen  \r\n\r\n opst&aring;r inden for 6 m&aring;neder efter det uvante arbejdes  \r\n\r\n p&aring;begyndelse,</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<I><P>eller</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">  \r\n\r\n<P>ii)</TD>  \r\n\r\n<TD WIDTH=\"38%\" VALIGN=\"TOP\">  \r\n\r\n<P>For&aring;rsaget af hurtigt gentagne og betydeligt kraftbetonede  \r\n\r\n arbejdsbev&aelig;gelser.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Eksempelvis: filetsk&aelig;rere og slagteriarbejdere, der udf&oslash;rer  \r\n\r\n udsk&aelig;ringsarbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Forandringer i skulderleddets rotatorsener</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Eksempelvis: rotator cuff syndrom, skuldertendinit.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">  \r\n\r\n<P>1)</TD>  \r\n\r\n<TD WIDTH=\"38%\" VALIGN=\"TOP\">  \r\n\r\n<P>opst&aring;et efter l&aelig;ngere tids statisk belastning med armene  \r\n\r\n h&aelig;vet over skulderh&oslash;jde eller</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">  \r\n\r\n<P>2)</TD>  \r\n\r\n<TD WIDTH=\"38%\" VALIGN=\"TOP\">  \r\n\r\n<P>opst&aring;et efter flere &aring;rs kraftbetonet og skulderbelastende  \r\n\r\n arbejde.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Normalt l&aelig;gges der v&aelig;gt p&aring; 6-8 &aring;rs kraftbetonet og  \r\n\r\n skulderbelastende arbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>7.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Kroniske nakke-skuldersmerter, n&aring;r f&oslash;lgende betingelser er  \r\n\r\n opfyldt:</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Der skal have v&aelig;ret tale om repetitivt, monotont  \r\n\r\n pr&aelig;cisionsarbejde med statisk belastning af skulder&aring;get og  \r\n\r\n fiksering af nakken.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som eksempel kan n&aelig;vnes industrielt syarbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Der skal have v&aelig;ret tale om en arbejdsperiode p&aring; 108  \r\n\r\n m&aring;neder inden for 12 &aring;r eller af en samlet varighed p&aring; 18  \r\n\r\n &aring;r med 9 m&aring;neders arbejde om &aring;ret.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som udgangspunkt l&aelig;gges der v&aelig;gt p&aring; 30 timers ugentligt  \r\n\r\n arbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Lidelsen skal have medf&oslash;rt arbejdsoph&oslash;r eller jobskifte til  \r\n\r\n kvalitativt forskelligt arbejde, og lidelsen m&aring; ikke herefter  \r\n\r\n v&aelig;re forv&aelig;rret.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>d)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Der m&aring; ikke v&aelig;re v&aelig;sentlige konkurrerende &aring;rsager,  \r\n\r\n dvs. lidelser, der p&aring; anden m&aring;de kan forklare symptomerne.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Eksempelvis: rheumatoid arthrit, visse former for gigtiske forandringer i  \r\n\r\n halshvirvels&oslash;jlen.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>8.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Sygdomme i ledkapslernes slims&aelig;kke for&aring;rsaget af vedvarende  \r\n\r\n tryk.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Eksempelvis: bet&aelig;ndelse i slims&aelig;k foran kn&aelig;skal efter  \r\n\r\n kn&aelig;liggende arbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>9.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Menisklidelser opst&aring;et ved arbejde i hugsiddende stilling under  \r\n\r\n trange arbejdsforhold.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>10.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Nervelammelser som f&oslash;lge af udefra kommende tryk.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>11.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Kroniske l&aelig;nderyglidelser med smerter, n&aring;r f&oslash;lgende  \r\n\r\n betingelser er opfyldt:</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Eksempelvis lumbago/ischias, lumbal(e) discusprolaps(er) eller  \r\n\r\n degenerative forandringer med daglige eller hyppige smerter.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>enten</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>At der har v&aelig;ret tale om rygbelastende l&oslash;ftearbejde gennem  \r\n\r\n 8-10 &aring;r med l&oslash;ft af genstande. Der skal som udgangspunkt have  \r\n\r\n v&aelig;ret tale om en samlet daglig l&oslash;ftem&aelig;ngde p&aring; 8-10  \r\n\r\n tons eller derover, hvor den enkelte genstand har v&aelig;ret tung.</P>  \r\n\r\n<P>Tr&aelig;k opad sidestilles med l&oslash;ft.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som udgangspunkt skal den enkelte byrde have vejet:</P>  \r\n\r\n<P>50 kg for m&aelig;nd eller 35 kg for kvinder.</P>  \r\n\r\n<P>Kravet til v&aelig;gten af den enkelte byrde neds&aelig;ttes, hvis der har  \r\n\r\n v&aelig;ret tale om</P><DIR>  \r\n\r\n<P>1)&#9;l&oslash;ft over skulderh&oslash;jde,</P>  \r\n\r\n<P>2)&#9;mere end &eacute;t l&oslash;ft i minuttet,</P>  \r\n\r\n<P>3)&#9;l&oslash;ft under vrid,</P>  \r\n\r\n<P>4)&#9;l&oslash;ft i foroverb&oslash;jet stilling,</P>  \r\n\r\n<P>5)&#9;l&oslash;ft i mere end en halv arms afstand fra kroppen.</DIR>  \r\n\r\n</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Det enkelte l&oslash;ft skal dog udg&oslash;re mindst 8 kg for m&aelig;nd  \r\n\r\n og 5 kg for kvinder.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kravene til den tidsm&aelig;ssige udstr&aelig;kning (8-10 &aring;r) vil  \r\n\r\n afh&aelig;nge af den samlede daglige l&oslash;ftem&aelig;ngde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Tidskravet kan neds&aelig;ttes, hvis der har v&aelig;ret tale om en  \r\n\r\n belastning p&aring; v&aelig;sentlig over 10 tons dagligt, dog aldrig til  \r\n\r\n mindre end 3-4 &aring;r.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kravene til den samlede daglige l&oslash;ftem&aelig;ngde (8-10 tons) kan  \r\n\r\n neds&aelig;ttes, hvis der har v&aelig;ret tale om en us&aelig;dvanligt lang  \r\n\r\n belastningsperiode, s&aelig;rlige belastningsforhold eller en kombination af  \r\n\r\n belastninger.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som eksempler p&aring; s&aelig;rlige belastningsforhold eller kombination  \r\n\r\n af belastningsforhold kan n&aelig;vnes:</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Arbejde inden for fiskerierhvervet, l&oslash;ftearbejde under trange  \r\n\r\n pladsforhold, kombination af l&oslash;ftearbejde og jernbinding i  \r\n\r\n foroverb&oslash;jet stilling i forbindelse med l&oslash;ftearbejde.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Den samlede daglige l&oslash;ftem&aelig;ngde kan dog ikke neds&aelig;ttes  \r\n\r\n til mindre end 4-6 tons   alt efter arten af belastningsforholdene.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>eller</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>at der har v&aelig;ret tale om regelm&aelig;ssigt l&oslash;ftearbejde  \r\n\r\n gennem mindst 8 &aring;r, hvor ekstremt tunge enkeltl&oslash;ft udf&oslash;rt  \r\n\r\n under akavede omst&aelig;ndigheder har v&aelig;ret en almindelig del af  \r\n\r\n arbejdet, n&aring;r der samtidig har v&aelig;ret tale om en samlet daglig  \r\n\r\n l&oslash;ftem&aelig;ngde p&aring; ikke under 3-3½ tons.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som udgangspunkt skal den enkelte genstand have vejet 100 kg eller  \r\n\r\n derover.</P>  \r\n\r\n<P>Kravet til v&aelig;gten af den enkelte genstand kan neds&aelig;ttes  \r\n\r\n til:</P>  \r\n\r\n<P>75-100 kg for m&aelig;nd og 50-75 kg for kvinder ved 1 af de under punkt  \r\n\r\n 1)-5) n&aelig;vnte faktorer,</P>  \r\n\r\n<P>50-75 kg for m&aelig;nd og 35-50 kg for kvinder ved 2 af de under 1)-5)  \r\n\r\n n&aelig;vnte faktorer,</P>  \r\n\r\n<P>50 kg for m&aelig;nd og 35 kg for kvinder ved 3 af de under punkt 1)-5)  \r\n\r\n n&aelig;vnte faktorer.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<I><P>eller</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>at der har v&aelig;ret tale om mindst 10 &aring;rs rygbelastende arbejde  \r\n\r\n med pleje af voksne eller st&oslash;rre handicappede b&oslash;rn.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som udgangspunkt skal der have v&aelig;ret tale om rygbelastende  \r\n\r\n plejearbejde i forbindelse med f.eks. sengeliggende, plejekr&aelig;vende  \r\n\r\n k&oslash;restolsbrugere eller andre plejekr&aelig;vende  \r\n\r\n patient-/beboergrupper og rygbelastende plejearbejde svarende til mindst 20  \r\n\r\n daglige personl&oslash;ft/h&aring;ndteringer/forflytninger.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kravene til det daglige antal  \r\n\r\n personl&oslash;ft/h&aring;ndteringer/forflytninger kan neds&aelig;ttes, hvis  \r\n\r\n der har v&aelig;ret tale om v&aelig;sentlig mere end 10 &aring;r med  \r\n\r\n rygbelastende arbejde, eller hvis omst&aelig;ndighederne ved plejearbejdet  \r\n\r\n har v&aelig;ret us&aelig;dvanligt belastende.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kravene til det daglige antal  \r\n\r\n personl&oslash;ft/h&aring;ndteringer/forflytninger kan dog ikke  \r\n\r\n neds&aelig;ttes til under 10.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=6>  \r\n\r\n<I><P>eller</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>d)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>at der har v&aelig;ret tale om uds&aelig;ttelse for helkropsvibrationer  \r\n\r\n gennem 8-10 &aring;r.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Som udgangspunkt skal der have v&aelig;ret tale om daglig uds&aelig;ttelse  \r\n\r\n for helkropsvibrationer i form af k&oslash;rsel p&aring; uj&aelig;vnt  \r\n\r\n underlag med kraftigt vibrerende k&oslash;ret&oslash;jer som f.eks.  \r\n\r\n b&aelig;ltek&oslash;ret&oslash;jer, entrepren&oslash;rmaskiner, kraner,  \r\n\r\n traktorer og andre landbrugsmaskiner, trucks eller skovbrugsmaskiner.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kravet til den tidsm&aelig;ssige udstr&aelig;kning kan neds&aelig;ttes,  \r\n\r\n hvis der har v&aelig;ret tale om s&aelig;rligt kraftig uds&aelig;ttelse eller  \r\n\r\n manglende affjedring/ st&oslash;dd&aelig;mpning. Tidskravet kan dog ikke  \r\n\r\n neds&aelig;ttes til mindre end 3-4 &aring;r.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>12.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Karpaltunnelsyndrom opst&aring;et efter l&aelig;ngerevarende,  \r\n\r\n repetitivt,</P>  \r\n\r\n<P>ikke varieret, kraftbetonet, </P>  \r\n\r\n<P>h&aring;ndledsbelastende arbejde.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>F.eks. udsk&aelig;ringsarbejde, hvor specielt h&aring;ndled og/eller  \r\n\r\n underarm belastes med vridebev&aelig;gelser under samtidig anvendelse af  \r\n\r\n betydelig muskelstyrke.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe F</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Kr&aelig;ftlidelser, som ikke er n&aelig;vnt andetsteds:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Kr&aelig;ftlidelser for&aring;rsaget af et stof eller p&aring;virkning,  \r\n\r\n der er optaget p&aring; IARC's til enhver tid g&aelig;ldende liste over  \r\n\r\n kr&aelig;ftfremkaldende stoffer og p&aring;virkninger under kategori 1 og 2a,  \r\n\r\n n&aring;r der er en veldokumenteret sammenh&aelig;ng mellem en  \r\n\r\n erhvervsm&aelig;ssig uds&aelig;ttelse og en &oslash;get risiko for den  \r\n\r\n p&aring;g&aelig;ldende kr&aelig;ftlidelse hos mennesker, jf. bilag 2.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Det betyder, at for kategori 1's vedkommende er de stoffer og  \r\n\r\n p&aring;virkninger udeladt, hvor der som udgangspunkt ikke er tale om en  \r\n\r\n erhvervsm&aelig;ssig uds&aelig;ttelse. I kategori 2a er de stoffer og  \r\n\r\n p&aring;virkninger udeladt, hvor der som udgangspunkt ikke er en  \r\n\r\n erhvervsm&aelig;ssig uds&aelig;ttelse, samt de stoffer og p&aring;virkninger,  \r\n\r\n hvor der heller ikke er en veldokumenteret sammenh&aelig;ng mellem en  \r\n\r\n erhvervsm&aelig;ssig uds&aelig;ttelse og en &oslash;get risiko for den  \r\n\r\n p&aring;g&aelig;ldende kr&aelig;ftlidelse hos mennesker.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe G</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Sygdomme i t&aelig;nder og tandk&oslash;d:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Risikoomr&aring;der:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Sukker- og melcaries lokaliseret is&aelig;r p&aring; fort&aelig;ndernes  \r\n\r\n facialflader (forflader). Denne caries skal v&aelig;re udviklet efter mindst  \r\n\r\n 5 &aring;rs samlet arbejde i sukker- og melbranchen inden for en periode  \r\n\r\n p&aring; h&oslash;jst 7 &aring;r. Derudover skal lidelsen v&aelig;re  \r\n\r\n dokumenteret senest ved arbejdsoph&oslash;r i branchen.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Mel- og br&oslash;dfabrikker, kiks- og vaffelfabrikker,  \r\n\r\n chokoladefabrikker, bagerier o. l.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<P>Tandslid (abrasion) af tredie eller fjerde grad af adskillige t&aelig;nder  \r\n\r\n i det permanente tands&aelig;t lokaliseret til t&aelig;ndernes tyggeflader  \r\n\r\n og/eller fort&aelig;ndernes sk&aelig;rekant. Tandsliddet skal v&aelig;re  \r\n\r\n udviklet efter mindst 5 &aring;rs samlet produktionsarbejde i et  \r\n\r\n arbejdsmilj&oslash; med p&aring;vist slibemiddel i luften inden for en  \r\n\r\n periode p&aring; h&oslash;jst 7 &aring;r. Derudover skal lidelsen v&aelig;re  \r\n\r\n dokumenteret senest ved arbejdsoph&oslash;r i branchen.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>Klinke- og lervareindustrien, isolationsmaterialeindustrien, stenbrud og  \r\n\r\n granitvareindustrien, beton- og cementst&oslash;berier, besk&aelig;ftigelse  \r\n\r\n ved metalslibning.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>  \r\n\r\n<B><P ALIGN=\"CENTER\">Gruppe H</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD VALIGN=\"TOP\" COLSPAN=15>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<I><P>Fosterskader:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<I><P>Sygdommens art:</I></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>  \r\n\r\n<P>Nedenn&aelig;vnte fosterskader anerkendes med barnet som  \r\n\r\n erstatningsberettiget efter lovens §&nbsp;10, stk.&nbsp;1, nr. 1, under  \r\n\r\n foruds&aelig;tning af, at det dokumenteres, at moderen i sit arbejde under  \r\n\r\n graviditeten har p&aring;draget sig en infektion som n&aelig;vnt under 1)  \r\n\r\n eller har v&aelig;ret udsat for en p&aring;virkning som n&aelig;vnt under 2),  \r\n\r\n 3) og 4), n&aring;r tillige de i bekendtg&oslash;relsens §&nbsp;1  \r\n\r\n n&aelig;vnte generelle betingelser er opfyldt:</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=8>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>1.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>Infektioner:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Cytomegalovirus.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kongenit cytomegalvirusinfektion.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Hepatitis B virus.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Neonatal hepatitis B virusinfektion medf&oslash;rende kronisk  \r\n\r\n b&aelig;rertilstand.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Herpes Simplex Virus.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Neonatal herpes.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>d)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Human immundefekt Virus. (HIV).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kongenit eller neonatal HIV-infektion.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>e)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Listeria.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Hjernebet&aelig;ndelse.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>f)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Parvovirus B-19.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kongenitinfektion.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>g)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Kongenit rubellasyndrom (r&oslash;de hunde virus).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kongenit rubellasyndrom.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>h)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Toxoplasmose (haresyge).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Microcephali, hydrocephalus, nethindebet&aelig;ndelse,  \r\n\r\n leverbet&aelig;ndelse.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>i)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Varicella Zoster virus (skoldkopvirus).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Kongenit varicellasyndrom eller neonatalvaricella.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>2.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>Kemiske stoffer:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Methylkviks&oslash;lv.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Microcephali, mental retardering.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Bly.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Hjernebet&aelig;ndelse, retarderet udvikling.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>c)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>PCB.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Lav f&oslash;dselsv&aelig;gt, hudforandringer.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>3.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>Andre skadelige p&aring;virkninger:</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>a)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Str&aring;ling (radioaktivitet).</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>Microcephali, maligne sygdomme.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>b)</TD>  \r\n\r\n<TD WIDTH=\"41%\" VALIGN=\"TOP\" COLSPAN=4>  \r\n\r\n<P>Ekstrem fysisk arbejdsbelastning.</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=3>  \r\n\r\n<P>For tidlig f&oslash;dsel og komplikationer hertil.</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"4%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>4.</TD>  \r\n\r\n<TD WIDTH=\"44%\" VALIGN=\"TOP\" COLSPAN=7>  \r\n\r\n<I><P>Fysiske traumer (ulykker og vold).</I></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\" COLSPAN=4>&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"49%\" VALIGN=\"TOP\" COLSPAN=2>  \r\n\r\n<P>For tidlig f&oslash;dsel og komplikationer hertil.</TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"Bilag 1\" -->  \r\n\r\n<A NAME=\"\"B2\"\"></A>\r\n\r\n<DIV CLASS=BILAG ID=\"B2\">  \r\n\r\n<HR width=70% align=center>  \r\n\r\n<B><FONT SIZE=4><P ALIGN=\"RIGHT\">Bilag 2</P>  \r\n\r\n</FONT>  \r\n\r\n<P ALIGN=\"CENTER\">Uddrag af IARC's liste, jf. bilag 1, Gruppe F.<A HREF=\"#SN501\" NAME=\"_SN501\"><SUP>1)</SUP></A> &nbsp;<BR>  \r\n\r\n Dansk (engelsk)</P></B>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=1 WIDTH=529>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Gruppe 1</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Lidelsens art:</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>4-Aminobiphenyl&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Arsen og dets forbindelser (arsenic and arsenic compounds)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft, lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Asbest (asbestos)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mesotheliom, lungekr&aelig;ft, strubekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Benzen (benzene)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Akut myeloid leuk&aelig;mi</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Benzidin (benzidine)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Beryllium og dets forbindelser (beryllium and beryllium  \r\n\r\n compounds)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bis(chloromethyl)ether og chloromethyl methylether (teknisk grad)  \r\n\r\n (bis(cloromethyl)ether and chloromethyl methylether (technical  \r\n\r\n grade))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Cadmium og dets forbindelser (cadmium and cadmium compounds)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kromforbindelser (chromium compounds)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Crystalline silika&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>2,3,7,8-Tetrachlorodibenzo-para-dioxin (dioxin)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Alle kr&aelig;ftformer</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Erionit (erionite)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mesotheliom</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis B-virus&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis C-virus&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sennepsgas (svovlsennep) (mustard gas (sulphur mustard))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>2-Naphthylamin (2-naphthylamine)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nikkelforbindelser (nickel compounds)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft, n&aelig;se-og bihulekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Radon og dets nedbrydningsprodukter (radon and its decay  \r\n\r\n products)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Solstr&aring;ling (solar radiation)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Talkum med asbestiformfibre (talc containing asbestiform fibres)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tr&aelig;st&oslash;v (wood dust)&#9;</P>  \r\n\r\n</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sekr&aelig;ft, n&aelig;sebihulekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Vinylchlorid (vinyl chloride)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Prim&aelig;r leverkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Blandinger (mixtures)</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stenkulstj&aelig;rebeg (coal-tar pitch)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft, lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stenkulstj&aelig;re (coal-tar)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft, lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mineralolie, ubehandlet og let behandlet (mineral oil, untreated and  \r\n\r\n mildly treated)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skiferolie (shale-oil)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sod (soot)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Ekspositionsbetingelser (exposure circumstances)</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Aluminiumsproduktion (aluminium production)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Auramin, fremstilling af (auramine, manufacture of)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&oslash;vle- og skofremstilling og -reparation (boot and shoe  \r\n\r\n manufacture and repair)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kulforgasning (coal gasification)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft, bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Koksproduktion (coke production)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>M&oslash;bel- og skabsproduktion (furniture and cabinet making)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>H&aelig;matit-minedrift (under jorden) med uds&aelig;ttelse for radon  \r\n\r\n (haematite mining (underground) with exposure to radon)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Jern- og st&aring;lst&oslash;bning (iron and steel founding)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fremstilling af isopropylalkohol-fremstilling ved st&aelig;rk sur proces  \r\n\r\n (isopropanol manufacture (strong acid process))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bihulekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Magenta, fremstilling af (magenta, manufacture of)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Maler (erhvervsm&aelig;ssig uds&aelig;ttelse som) (painter (occupational  \r\n\r\n exposure as a))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gummiindustri (rubber industry)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&aelig;rke uorganiske syret&aring;ger indeholdende svovlsyre  \r\n\r\n (erhvervsm&aelig;ssig uds&aelig;ttelse for) (strong inorganic acid mists  \r\n\r\n containing sulphuric acid (occupational exposure to))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Strubekr&aelig;ft, lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Gruppe 2A</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Stoffer og grupper af stoffer (agents and groups of agents)</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>1,3-Butadien (1,3-butadiene)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lymfekr&aelig;ft, leuk&aelig;mi</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Para-chlor-ortho-toluidin og dets st&aelig;rke sure salte  \r\n\r\n (para-chloro-ortho-toluidine and its strong acid salts)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Alfa-Chlorinated Toluenes and Benzoyl Chloride (Combined  \r\n\r\n Exposures)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ethylenoxid (ethylene oxide)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leuk&aelig;mi</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Formaldehyd (formaldehyde)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sekr&aelig;ft, n&aelig;sesv&aelig;lgkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>4,4'-Methylbischloranilin (4,4'-methylene bis chloroaniline  \r\n\r\n (MOCA))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tetrachlorethylen (tetrachlorethylene)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Non-Hodgkin-lymfom</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Trichlorethylen (trichlorethylene)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverkr&aelig;ft, galdegangskr&aelig;ft, non-Hodgkin-lymfom</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Blandinger (mixtures)</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Creosot (creosotes)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Udst&oslash;dningsgasser fra dieselmotorer (diesel engine  \r\n\r\n exhaust)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft, bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ikke-arsenholdige insektbek&aelig;mpelsesmidler (erhvervsm&aelig;ssig  \r\n\r\n uds&aelig;ttelse ved spr&oslash;jtning og anvendelse af) (non-arsenical  \r\n\r\n insecticides (occupational exposures in spraying and application  \r\n\r\n of))&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Polychloreret biphenyl (polychlorinated biphenyl)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverkr&aelig;ft, galdegangskr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Ekspositionsbetingelser (exposure circumstances)</B></TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Glasfremstillingsindustri: fremstilling af kunstglas, beholdere og  \r\n\r\n lert&oslash;j (erhvervsm&aelig;ssig uds&aelig;ttelse ved) (glass  \r\n\r\n manufacturing industry: manufacture of art glass, containers and pressed ware  \r\n\r\n (occupational exposure in)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fris&oslash;r eller barber (erhvervsm&aelig;ssig uds&aelig;ttelse som)  \r\n\r\n (hairdresser or barber (occupational exposure as a)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"71%\" VALIGN=\"TOP\">  \r\n\r\n<P>Olieraffinering (erhvervsm&aelig;ssig uds&aelig;ttelse inden for)  \r\n\r\n (petroleum refining (occupational exposures in)&#9;</TD>  \r\n\r\n<TD WIDTH=\"3%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"26%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft og leuk&aelig;mi</TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<HR width=100 align=left>  \r\n\r\n<P><A NAME=\"SN501\" HREF=\"#_SN501\"><SUP>1)</SUP> </A>  </FONT><FONT SIZE=1>WHO  \r\n\r\n International Agency for Research on Cancer. IARC monographs on the  \r\n\r\n evaluation of cardinogenic risks to humans, IARC Monographs Volumes 1-67,  \r\n\r\n Lyon 1996.</P>  \r\n\r\n</FONT>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"Bilag 2\" -->  \r\n\r\n<A NAME=\"\"B3\"\"></A>\r\n\r\n<DIV CLASS=BILAG ID=\"B3\">  \r\n\r\n<HR width=70% align=center>  \r\n\r\n<B><FONT SIZE=4><P ALIGN=\"RIGHT\">Bilag 3</P>  \r\n\r\n</FONT>  \r\n\r\n<P ALIGN=\"CENTER\">Stikordsregister</P>  \r\n\r\n</B>  \r\n\r\n<P>Stikordsregistret indeholder lidelser, p&aring;virkninger og begreber, der  \r\n\r\n er n&aelig;vnt i bilag 1 og 2, jf. bekendtg&oslash;relsens §&nbsp;2.</P>  \r\n\r\n<P>Selvom lidelsen og/eller p&aring;virkningen er n&aelig;vnt i fortegnelsen,  \r\n\r\n indeb&aelig;rer det ikke n&oslash;dvendigvis, at lidelsen og/eller  \r\n\r\n p&aring;virkningen er omfattet af samme fortegnelse. Der skal g&oslash;res  \r\n\r\n opm&aelig;rksom p&aring;, at b&aring;de de generelle betingelser, som de  \r\n\r\n fremg&aring;r af §&nbsp;1 i fortegnelsen, og de s&aelig;rlige betingelser  \r\n\r\n n&aelig;vnt i de enkelte punkter, skal v&aelig;re opfyldt, jf. §&nbsp;2.</P>  \r\n\r\n<P ALIGN=\"JUSTIFY\"></P>  \r\n\r\n<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=1 WIDTH=529>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Lidelse/p&aring;virkning/begreb:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>Gruppe:</B></TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>1,3-Butadiene&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>2-Naphtylamin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>2,3,7,8-Tetrachlorodibenzo-para-dioxin</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>4-Aminobiphenyl&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>4,4'-Methylbischloranilin (MOCA)&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>A:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Abrasion&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Acid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Acid salts&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Acrylonitril&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Alfa-Chlorinated Tolunes, Benzoyl Chloride...</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Allergisk alveolitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Aluminium&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,4, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Aluminiumsproduktion&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Aminobiphenyl&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ammoniak&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,8</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Am&oslash;biasis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Anhydrider&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Antracen&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Aplastisk an&aelig;mi&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Arsen, arsenic&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Asbest, asbestos&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Asfalt&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Astma&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3,5,9, Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Auramine&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>B:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Beg&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Benzen&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16b, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Benzidin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Beryllium, Berylliumlunge&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,2, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bihulekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bird Breeder's lung&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bis(cloromethyl)ether&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Blodkr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Blodmangel&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bly&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,11, Gruppe H,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aelig;rekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17, Gruppe F, Gruppe 1, Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bl&aring;syre&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Brom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bronchitis, kronisk&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,14, Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bronchogent carcinom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bronchopulmonale lidelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,4</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Bughindekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Butadien&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Byssinosis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>C:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Cadmium, Cadmiumcompounds&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1, se ogs&aring; kadmium</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Caries, sukker og mel&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Chloromethylether&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Chromium compounds&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Cirrhosis hepatitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A, 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Coalgasification&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Coal-tar pitches&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Coal-tars&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Coke production&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Conjunktivitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Creosot&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Cyanater, cyansalte, cyanforbindelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Cytomegalovirus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>D:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dampe&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,4, Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Demens, pr&aelig;senil&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,11</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Denguefeber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dieselmotorer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dimetylformamid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dyr, dyrisk materiale&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dyr, dyriske produkter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5b, Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Dyrisk protein&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>D&oslash;vhed&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>E:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Eksem, toksisk&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Eksem, allergisk&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5, Gruppe A,9, Gruppe B,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ekstrem fysisk arbejdsbelastning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,3b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Enzymer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Epicondylitis lateralis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6bi og ii</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Epoxyresiner&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Erionit&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ethylenoxid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>F:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>»Farmer's lung»&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Farvestoffer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fiksering af nakke&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Flammeh&oslash;vlingsr&oslash;g&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fluor&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fluorose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Formaldehyd&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fosfor&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,10</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fosgen&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fosterskader&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Framboesi&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fysiske traumer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,4</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Fysiske p&aring;virkninger&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>F&oslash;dsel, for tidlig&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,3b og 4a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>F&oslash;dselsv&aelig;gt, lav&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,2c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>G:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Galdegangskr&aelig;ft&#9;</P>  \r\n\r\n<P>Gigtiske forandringer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</P>  \r\n\r\n<P>Gruppe E,7d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Glasfremstillingsindustri&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Glomerulonephritis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gr&aring; st&aelig;r&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E, Gruppe H,1a og b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gul feber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gummiindustri&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>H:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Haresyge&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1h</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis B-virus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1b, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis toxica&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3, Gruppe A,16a, Gruppe A,17</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hepatitis C-virus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Herpes simplex&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hexan&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hjernebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1e, Gruppe H,2b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hjerneskade, organisk&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3, Gruppe A,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hjerneskade, toksisk&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hjerneskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,12</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudforandringer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,2c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudkr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1, Gruppe B,1, Gruppe F, Gruppe 1, Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudlidelser, allergiske&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudlidelser, andre&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudlidelser, pr&aelig;cancer&oslash;se&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hudsygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hugsiddende stilling&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,9</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Human immundefekt virus (HIV)&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hurtigt gentagne bev&aelig;gelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6bii</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Hvide fingre&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>H&aelig;matit-minedrift&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>H&aring;rtab&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,13</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>I:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>IARC&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Infektion&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Infektioner, infekti&oslash;se&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Infekti&oslash;se sygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D, Gruppe H,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Insektbek&aelig;mpelsesmidler&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ioniserende str&aring;ling&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Iron founding&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Isocyanater&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3, Gruppe C,5d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Isoleringsst&oslash;v&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Isopropanol manufacture&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Isopropylalkohol&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>J:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Jern- og st&aring;lst&oslash;bning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Jod&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A, 15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>K:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kadmium&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,14</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kalvekastningsfeber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Karpaltunnelsyndrom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,5 og 12</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kemiske stoffer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A, Gruppe H,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Klor&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Klorede opl&oslash;sningsmidler&#9;</P>  \r\n\r\n<P>Knogle- og ledsygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16a</P>  \r\n\r\n<P>Gruppe E,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kobolt&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,9</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Koksproduktion&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Komprimeret luft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,4</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Korn- og foderstoffer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kraftbetonet&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a og b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Krom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kromforbindelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kronisk bronchitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Se bronchitis</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kroniske nakke-skuldersmerter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Se nakke-skuldersmerter</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2c og d, Gruppe F</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kulbrinter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kulforgasning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kulilte&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kunstharpiks&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kviks&oslash;lv&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kv&aelig;lstof&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Kv&aelig;lstofilter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,8</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>L:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Larynx-cancer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ledsygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leishmaniose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lepra&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leuk&aelig;mi&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16, Gruppe E,1, Gruppe F, Gruppe 1 og 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverbet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Se hepatitis</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverkr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1 og 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Leverskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Listeria&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1e</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Luftfugtersyge&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungeasbestose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,14</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungefibrose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungehindebindev&aelig;vsdannelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1,5,9, Gruppe C,2d, Gruppe F, Gruppe 1 og 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungelidelse, obstruktiv&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lungeskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,8,10,12 og 15</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lunge&oslash;dem&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,10</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Lymfekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>L&aelig;nderyglidelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E, 11</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>M:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Magenta&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Malaria&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Maler&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Maligne sygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,3a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Maltafeber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mangan&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Melcaries&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Menisklidelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,9</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mental retardering&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,2a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mesotheliom, malignt&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,2c, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Metallunge, h&aring;rd&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,9</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Methylbischloranilin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Methylkviks&oslash;lv&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H, 2a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Metylbutylketon&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Microcephali&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,2a, 3a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Miltbrand&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mineral oils&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mineralolie&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mineralske olier&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mushroom worker's lung&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Mustard Gas&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Myeloid leuk&aelig;mi&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Se leuk&aelig;mi</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>M&oslash;bel- og skabsproduktion&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>N:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nakke-skuldersmerter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Naphtylamin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nephritis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,11</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nephrotisk syndrom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nervebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1, 13 og 16c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nervelammelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,10</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Neuropati&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nickel compounds&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nikkel&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,9</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nikkelforbindelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Non-arsenical insecticides&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Non-Hodgkin-lymfom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Nyreskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,4,6,11 og 16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sebihulekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;seskillev&aelig;g, perforation&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>N&aelig;sesv&aelig;lgkr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>O:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Olieraffinering&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe 1, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Organisk hjerneskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,3 og 6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Organiske kv&aelig;lstof(nitrogen)forbindelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,17</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Organiske materialer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Organiske opl&oslash;sningsmidler&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Ornitose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>P:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Pappatacifeber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Para-Chlor-ortho toluidin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Paralysis agitans&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Parasit&aelig;re sygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Parvovirus B-19&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1f</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>PCB&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,2c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Peritendinitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Persulfatsalte&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Pest&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Petroleum refining&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Planter, planteprodukter&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Plejearbejde&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E, 11c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Plettyfus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Poliomyelitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1f</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Polychloreret biphenyl&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Polyneuropati&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1,10,11 og 16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Prim&aelig;r leverkr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Pr&aelig;cisionsarbejde&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>R:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Radioaktivitet&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,3a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Radon&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Repetitivt&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Retardering, mental&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1a og b, 2a og b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rheumatoid arthrit&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rhinitis allergica&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Richettsia&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rotator cuff syndrom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rotatorsener&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rubber industry&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rubella syndrom&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1g</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rygere&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Rystelammelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>R&oslash;de hunde&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1g</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>R&oslash;g&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>R&aring;parafin&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>S:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Salpetersyre&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,8</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Seneskedehindebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sennepsgas&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Shale-oils&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Silika&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Siliciumforbindelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Silicose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skiferolie&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skoldkopvirus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1i</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skrumpelever&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skulderled&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Skulder&aring;g&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,7a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Slibemiddel&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Slimhindebet&aelig;ndelse, &oslash;vre luftveje, &oslash;jne&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Slims&aelig;k&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,8</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sod&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1, Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Solstr&aring;ling&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Solar radiation&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Soots&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Springfinger&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stafylokokker&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Statisk belastning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Steel founding&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stenkulstj&aelig;re&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stenkulstj&aelig;rebeg&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stenoserende tendovaginitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Stivkrampe&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Strubekr&aelig;ft&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Str&aring;leenergi&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Str&aring;ling&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,1, Gruppe H,3a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&aelig;r, gr&aring;&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&oslash;j&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&oslash;v&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,4,5 og 7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>St&oslash;vle- og skofremstilling&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Grupe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sukker- og melcaries&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Se caries</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sulfuric acid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Sulphur mustard&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svampesporer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svejsning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svovlbrinte&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,12</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svovldioxid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,12</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svovlsennep&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Svovlsyre&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,12</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Synsforstyrrelser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,13</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>T:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Talc containing asbestiform fibres&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Talkum&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tallium&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,13</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tandslid&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tendinit, skulder&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6c</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tendinitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tendovaginitis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tennisalbue&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tetrachlorethylen&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tilbagefaldsfeber&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tj&aelig;re&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tobaksforbrug&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Toksiske eksemer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe B,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Toksisk hjerneskade&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,11, Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Toxoplasmose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1h</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Traumer, fysiske&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,4</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Trichlorethylen&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tropesygdomme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Trypanosomiasis&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tr&aelig;forarbejdning&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tr&aelig;st&oslash;v&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tuberkulose&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,2</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tuberkul&oslash;s smitte&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Tungh&oslash;righed&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,3</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>T&aelig;nder og tandk&oslash;d&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe G</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>U:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Udst&oslash;dningsgasser&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 2A</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Underarme&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Uspecifikt st&oslash;v&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe C,7</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Uvant arbejde </TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6a og b</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>V:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Vanadium&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,14</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Varicella-Zoster virus&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe H,1i</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Varieret arbejde&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,6</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Vibrationer&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe E,5, Gruppe E,11d</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Vinyl chloride&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>W:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Weil's syge&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe D,1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>Wood dust&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe F, Gruppe 1</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>&Oslash;:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>&Oslash;jenslimhindebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>&Oslash;vre luftvejsslimhindebet&aelig;ndelse&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,5</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<B><P>&Aring;:</B></TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n</TR>  \r\n\r\n<TR><TD WIDTH=\"61%\" VALIGN=\"TOP\">  \r\n\r\n<P>&Aring;ndssv&aelig;kkelse, tidlig&#9;</TD>  \r\n\r\n<TD WIDTH=\"4%\" VALIGN=\"TOP\">&nbsp;</TD>  \r\n\r\n<TD WIDTH=\"35%\" VALIGN=\"TOP\">  \r\n\r\n<P>Gruppe A,11, Gruppe A,16</TD>  \r\n\r\n</TR>  \r\n\r\n</TABLE>  \r\n\r\n<P ALIGN=\"JUSTIFY\"></P>  \r\n\r\n</FONT>  \r\n\r\n</DIV><!-- End of \"Bilag 3\" -->  \r\n\r\n</DIV>",
    "isHistorical": true,
    "editorialNotes": [],
    "alternativeMedia": [],
    "ressort": "Beskæftigelsesministeriet",
    "isReprint": false,
    "geografiskDaekningId": 0,
    "retsinfoKlassifikationId": 10,
    "caseHistoryReferenceGroup": [],
    "metadata": [
        {
            "displayName": "Offentliggørelsesdato",
            "displayValue": "26/11/2002"
        },
        {
            "displayName": "Accession",
            "displayValue": "B20020091805"
        },
        {
            "displayName": "Entydig dokumentidentifikation",
            "displayValue": "BE000321"
        },
        {
            "displayName": "Dato for førstegangsindlæggelse",
            "displayValue": "26/11/2002"
        },
        {
            "displayName": "Dato for indlæggelse",
            "displayValue": "16/03/2006"
        },
        {
            "displayName": "Dokumenttype",
            "displayValue": "Bekendtgørelse"
        },
        {
            "displayName": "Dokumentets rangering",
            "displayValue": "B "
        },
        {
            "displayName": "Forskriftens nummer",
            "displayValue": "918"
        },
        {
            "displayName": "År for udstedelse",
            "displayValue": "2002"
        },
        {
            "displayName": "Dato for underskrift",
            "displayValue": "18/11/2002"
        },
        {
            "displayName": "Offentliggjort i (publiceringsmedie)",
            "displayValue": "Lovtidende A"
        },
        {
            "displayName": "Administrerende myndighed",
            "displayValue": "Arbejdsskadestyrelsen"
        },
        {
            "displayName": "Ressortministeriets journalnummer",
            "displayValue": "Beskæftigelsesmin.,<br />Arbejdsskadestyrelsen, j.nr. 95-4067-4"
        }
    ],
    "pdfLink": {
        "isPdfAvailable": false
    },
    "documentFobTagGroup": [],
    "hasFobTags": false
}